Side-by-side comparison of AI visibility scores, market position, and capabilities
Wearable blood pressure monitoring sticker with OR-grade accuracy; awaiting FDA clearance after 500+ patient clinical studies for hospital surgery and home cardiovascular monitoring.
Vena Vitals is a medical device company developing wearable continuous blood pressure monitoring technology — manufacturing adhesive sensor stickers that provide operating room-grade blood pressure accuracy using photoplethysmography (PPG) and proprietary algorithms, without the discomfort or interruption of traditional cuff-based blood pressure measurement. Founded in 2019 in Irvine, California, Vena Vitals has completed clinical studies on 500+ patients and is preparing its FDA submission for clearance to market the device for in-hospital (surgical and critical care) and home monitoring applications.\n\nVena Vitals' wearable patch applies to the wrist or finger and continuously monitors blood pressure beat-by-beat using optical sensors — providing the continuous monitoring currently limited to invasive arterial line catheters in ICUs or intermittent readings from arm cuffs. Continuous non-invasive blood pressure monitoring is clinically valuable during surgery (where blood pressure fluctuates significantly) and for patients with cardiovascular conditions or sleep disorders where blood pressure patterns during sleep and activity provide diagnostic insight. The device targets a significant cost reduction compared to invasive arterial line monitoring.\n\nIn 2025, Vena Vitals is in the regulatory submission phase, positioning for FDA clearance that would unlock commercial deployment in hospitals and the growing consumer remote patient monitoring market. The continuous non-invasive blood pressure market is competitive — Samsung (Galaxy Watch blood pressure), Apple (researching blood pressure for Apple Watch), Withings, and medical device companies including Omron and iHealth are pursuing cuffless blood pressure monitoring. However, most consumer wearable approaches have not achieved clinical-grade accuracy, which is Vena Vitals' key differentiator. FDA clearance would position Vena Vitals for partnerships with hospital systems and RPM (remote patient monitoring) program operators.
Serverless GPU cloud platform for AI/ML with Python-native deployment and per-second billing; developer-favorite scaling from zero competing with Replicate and Beam for AI compute.
Modal is a serverless cloud computing platform purpose-built for AI and machine learning workloads — providing on-demand GPU compute that scales instantly from zero with per-second billing, container management, distributed training support, and a Python-native developer experience that makes running ML workloads in the cloud feel as simple as running code locally. Founded in 2021 in New York City and backed by Redpoint Ventures and other investors, Modal has grown rapidly as AI development has accelerated demand for flexible, developer-friendly GPU infrastructure.\n\nModal's developer experience is its primary differentiator — engineers write Python functions decorated with @modal.function() and deploy them to the cloud with a single command, with Modal handling container building, GPU provisioning, auto-scaling, and execution. The platform supports training jobs that need distributed compute across multiple GPUs, model serving endpoints that scale to zero when unused (eliminating idle GPU costs), and batch inference jobs that process large datasets. The per-second billing model means developers pay only for actual compute time, not provisioned instances.\n\nIn 2025, Modal competes in the AI infrastructure market with Replicate, Beam, Banana, and major cloud providers' managed ML services (AWS SageMaker, Google Vertex AI, Azure ML) for serverless GPU compute. The market for AI-specific cloud infrastructure has grown dramatically as the number of ML engineers deploying models to production has expanded — traditional cloud providers require significant DevOps expertise to use GPU instances effectively, while Modal's Python-native approach reduces the barrier to entry. Modal has attracted a strong developer following among AI researchers and ML engineers building production AI applications. The 2025 strategy focuses on growing the developer community, adding enterprise features (dedicated GPU capacity, private networking, compliance), and expanding the hardware options available (H100 GPUs, custom accelerators).
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.